Xiaolong Wang

1.7k total citations
86 papers, 1.2k citations indexed

About

Xiaolong Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Xiaolong Wang has authored 86 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 23 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in Xiaolong Wang's work include Urinary Bladder and Prostate Research (12 papers), Aortic Disease and Treatment Approaches (10 papers) and Aortic aneurysm repair treatments (9 papers). Xiaolong Wang is often cited by papers focused on Urinary Bladder and Prostate Research (12 papers), Aortic Disease and Treatment Approaches (10 papers) and Aortic aneurysm repair treatments (9 papers). Xiaolong Wang collaborates with scholars based in China, Germany and United States. Xiaolong Wang's co-authors include Hongjia Zhang, Ou Liu, Yanwen Qin, Martin Hennenberg, Christian G. Stief, Xinghuan Wang, Mengxin Lü, Yu Xiao, Bingsheng Li and Bin Sun and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaolong Wang

75 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolong Wang China 20 495 366 305 204 152 86 1.2k
Kohei Shomori Japan 24 775 1.6× 217 0.6× 266 0.9× 286 1.4× 397 2.6× 66 1.6k
Junjie Zhang China 23 856 1.7× 210 0.6× 767 2.5× 266 1.3× 92 0.6× 80 1.5k
Yong Qiao China 20 673 1.4× 333 0.9× 419 1.4× 315 1.5× 83 0.5× 77 1.6k
Anna Żuk United States 16 665 1.3× 162 0.4× 113 0.4× 299 1.5× 176 1.2× 31 1.7k
Zhao Wang China 20 476 1.0× 222 0.6× 298 1.0× 419 2.1× 90 0.6× 78 1.2k
Leslie S. Gewin United States 24 798 1.6× 219 0.6× 91 0.3× 192 0.9× 108 0.7× 44 1.7k
Seiji Kishi Japan 20 1.1k 2.2× 334 0.9× 101 0.3× 304 1.5× 151 1.0× 64 1.8k
Yinhuai Wang China 18 585 1.2× 262 0.7× 430 1.4× 166 0.8× 138 0.9× 86 1.1k
Gábor Lotz Hungary 21 332 0.7× 248 0.7× 183 0.6× 478 2.3× 225 1.5× 95 1.4k
Dorella Del Prete Italy 21 495 1.0× 258 0.7× 80 0.3× 169 0.8× 58 0.4× 64 1.3k

Countries citing papers authored by Xiaolong Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaolong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolong Wang more than expected).

Fields of papers citing papers by Xiaolong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolong Wang. The network helps show where Xiaolong Wang may publish in the future.

Co-authorship network of co-authors of Xiaolong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolong Wang. A scholar is included among the top collaborators of Xiaolong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolong Wang. Xiaolong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chang‐Jiu, et al.. (2025). Improving weld quality of 6061/7075 dissimilar aluminum alloy joints using laser oscillation welding. Materials Letters. 405. 139743–139743.
2.
Peng, Huiling, et al.. (2025). Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis. Neurosurgical Review. 48(1). 683–683.
3.
4.
5.
6.
7.
Yu, Qingfeng, Yeda Chen, Bingsheng Li, et al.. (2021). Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle. Acta Pharmaceutica Sinica B. 11(7). 1914–1930. 13 indexed citations
8.
Wang, Xiaolong, Bingsheng Li, Anna Ciotkowska, et al.. (2020). Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α1-blockers. European Journal of Pharmacology. 873. 172985–172985. 18 indexed citations
9.
Sun, Bin, et al.. (2020). Micro-RNA-183-5p acts as a potential diagnostic biomarker for atherosclerosis and regulates the growth of vascular smooth muscle cell. Journal of the Chinese Medical Association. 84(1). 33–37. 13 indexed citations
10.
Ni, Lihua, et al.. (2020). <p>Co-Expression Network Analysis Identified LTF in Association with Metastasis Risk and Prognosis in Clear Cell Renal Cell Carcinoma</p>. OncoTargets and Therapy. Volume 13. 6975–6986. 21 indexed citations
11.
Ma, Xiaobin, Chengxue Dang, Weili Min, et al.. (2019). Downregulation of APE1 potentiates breast cancer cells to olaparib by inhibiting PARP-1 expression. Breast Cancer Research and Treatment. 176(1). 109–117. 15 indexed citations
12.
Cheng, Yuan, Lu Xu, Min Sun, et al.. (2019). Cetuximab versus nimotuzumab for the treatment of advanced nasopharyngeal carcinoma: A network meta-analysis.. PubMed. 22(4). 1004–1010. 9 indexed citations
13.
Cheng, Yuan, Le Wang, Min Sun, et al.. (2018). Which neoadjuvant chemotherapy regimen should be recommended for patients with advanced nasopharyngeal carcinoma?. Medicine. 97(34). e11978–e11978. 14 indexed citations
14.
Li, Mingxun, Xubin Lu, Chenglong Zhang, et al.. (2018). In-depth characterization of the pituitary transcriptome in Simmental and Chinese native cattle. Domestic Animal Endocrinology. 66. 35–42. 6 indexed citations
15.
Lü, Mengxin, Qiangqiang Ge, Gang Wang, et al.. (2018). CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α. Cell Death and Disease. 9(10). 1046–1046. 44 indexed citations
16.
Wang, Xiaolong, et al.. (2017). Standardized diagnosis and treatment of thyroid nodules. 11(17). 2189–2192.
17.
Wang, Xiaolong, Lei Sun, Xi-Jing Wang, et al.. (2017). Acidified bile acids enhance tumor progression and telomerase activity of gastric cancer in mice dependent on c‐Myc expression. Cancer Medicine. 6(4). 788–797. 32 indexed citations
18.
Li, Jiachen, et al.. (2017). Iatrogenic acute aortic dissection induced by off-pump coronary artery bypass grifting. Medicine. 96(51). e9206–e9206. 7 indexed citations
19.
Wang, Xiaolong, et al.. (2015). Detorsion of the Pulmonary Torsion: A Rare Post-thoracotomy Complication. Heart Lung and Circulation. 25(3). e62–e63. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kohei Shomori Breakdown of academic impact, for papers by Junjie Zhang Breakdown of academic impact, for papers by Yong Qiao Breakdown of academic impact, for papers by Anna Żuk Breakdown of academic impact, for papers by Zhao Wang Breakdown of academic impact, for papers by Leslie S. Gewin Breakdown of academic impact, for papers by Seiji Kishi Breakdown of academic impact, for papers by Yinhuai Wang Breakdown of academic impact, for papers by Gábor Lotz Breakdown of academic impact, for papers by Dorella Del Prete
Rankless by CCL
2026